About: Complications of diuretic therapy in hepatic cirrhosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Complications of diuretic therapy in hepatic cirrhosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1966

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1966 (uk) im Mai 1966 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1966 (ast) scientific article published on 01 May 1966 (en)
publication date	wds:Q70065155-10B45CFD-79D1-4920-BAED-D1FB63625F50
publication date	1966-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70065155-630ED66B-E891-4579-A38F-5355079D89FD
language of work or name	English
cites work	wds:Q70065155-057D299B-51AC-47DF-A46B-C52FFC074A58 wds:Q70065155-0C08BD9B-F7E9-402B-9E8E-B5E2BEBF3356 wds:Q70065155-405D332F-D402-4D4C-9026-67EAB4C5250F wds:Q70065155-417E4818-1C63-45DA-9D05-48F820DA3CBB wds:Q70065155-58FECCC7-4815-450E-A9EC-1D5DFC9E1156 wds:Q70065155-8B72BA73-B101-4CFB-A6F7-0DFDBAF3F788 wds:Q70065155-A08C60B5-CBBA-4110-82B0-83FD2AF6B5D1 wds:Q70065155-A8AE027E-BAC7-49DA-98B4-4922591C8C21 wds:Q70065155-C9158254-F0F6-4924-AAB0-DCEEACCC3798 wds:Q70065155-D44F358D-9D63-4563-92B5-65D3D301D0F8 wds:Q70065155-E4A4FA0F-EB02-428E-AA49-4E81286A1BFD wds:Q70065155-E94FEE62-03DF-4399-A7B0-ACF19C302AC1 wds:Q70065155-F16D27AD-F19D-41D2-86D3-D93D76AF31F0
cites work	RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY Electrolyte and circulatory changes in terminal liver failure Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features SPIRONOLACTONE THERAPY AND GYNECOMASTIA The response of normal man to selective depletion of hydrochloric acid. Factors in the genesis of persistent gastric alkalosis Correction of metabolic alkalosis in man without repair of potassium deficiency. A re-evaluation of the role of potassium RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. II. FACTORS INFLUENCING MAXIMAL URINARY FLOW RATE The aetiology and management of ascites in patients with hepatic cirrhosis: a review Renal failure in Laennec's cirrhosis. II. Simultaneous determination of cardiac output and renal hemodynamics DIURETIC ACTION OF FUROSEMIDE Relation of acute potassium depletion to renal ammonium metabolism in patients with cirrhosis Chlorothiazide in control of ascites in hepatic cirrhosis
author name string	wds:Q70065155-5EBF5F93-5D5B-4A73-917D-E81E67708E73 wds:Q70065155-B51C6F01-C611-420C-B1EF-D8065465E201 wds:Q70065155-C0B8E67A-8C71-4900-98C9-87D829AF569A wds:Q70065155-C384DB55-4E0C-419C-81D9-CF27210B4950
author name string	A Scott S Sherlock B Senewiratne J G Walker
rdfs:label	Complications of diuretic therapy in hepatic cirrhosis (en) Complications of diuretic therapy in hepatic cirrhosis (nl)
skos:prefLabel	Complications of diuretic therapy in hepatic cirrhosis (en) Complications of diuretic therapy in hepatic cirrhosis (nl)
name	Complications of diuretic therapy in hepatic cirrhosis (en) Complications of diuretic therapy in hepatic cirrhosis (nl)
title	wds:Q70065155-E86C301F-13AD-42A5-B693-2BC5969A123F
title	Complications of diuretic therapy in hepatic cirrhosis (en)
page(s)	wds:Q70065155-6730FE8D-3622-415A-80F4-08BFE4211364
page(s)	1049-1052
instance of	wds:Q70065155-531BAF98-3294-468C-9A58-8EE27482B056
instance of	scholarly article
PubMed ID	wds:Q70065155-563B5119-5EE5-4806-8AA6-76DFF07DCAF0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4160838
PubMed ID	4160838
published in	wds:Q70065155-2E112833-F731-4DCA-81B3-82DE2FB12357
published in	The Lancet
issue	wds:Q70065155-1BFBDDD8-2EF3-4A72-A69A-29CD64C27D52
volume	wds:Q70065155-7B864657-BA20-4B1B-A0E2-D54C4CA18F3C
issue	7446
volume	1
DOI	wds:Q70065155-27A02914-2F49-43E0-ABEF-C53028E2B97C
DOI	http://dx.doi.org/10.1016/S0140-6736(66)91005-1
DOI	10.1016/S0140-6736(66)91005-1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70065155
is cites work of	Prognostic value of spontaneous hyponatremia in cirrhosis with ascites Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club Salt or no salt in the treatment of cirrhotic ascites: a randomised study Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety Spironolactone diuresis in patients with cirrhosis and ascites. Pharmacotherapy of ascites associated with cirrhosis Diuretics vs. paracentesis followed by diuretics in cirrhosis: effect on ascites opsonic activity and immunoglobulin and complement concentrations Profound hyponatremia in cirrhosis: a case report Use of bumetanide in the treatment of ascites due to liver disease A rational approach to the treatment of ascites Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. Ascites Renal function and diuretic therapy in infants and children. Part II. Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study Monitoring of transtubular potassium gradient in the diuretic management of patients with cirrhosis and ascites Serum sodium, renal function, and survival of patients with end-stage liver disease A European survey on the treatment of ascites in cirrhosis Reabsorption of sodium in the proximal renal tubule in cirrhosis of the liver Advantages of treatment of ascites without sodium restriction and without complete removal of excess fluid Combined Ascitic-Fluid and Furosemide Infusion in the Management of Ascites Management of primary and secondary hyperaldosteronism Amiloride ('MK 870') in patients with ascites due to cirrhosis of the liver Usefulness of Amiloride Hydrochloride (MK‐870) As an Adjuvant in Long‐Term Treatment of Hepatic Cirrhosis Use of Metolazone in the Treatment of Ascites due to Liver Disease Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour Hepatic encephalopathy Diuretics. II. Clinical considerations Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites Bumetanide: A New Loop Diuretic (Bumex, Roche Laboratories) Treating the ascites of cirrhosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software